[Consistency of ALK Ventana-D5F3 immunohistochemistry interpretation in lung adenocarcinoma among Chinese histopathologists].
|
| Abstract |
Objective: To understand the consistency of ALK Ventana-D5F3 immunohistochemistry (IHC) interpretation in Chinese lung adenocarcinoma among histopathologists from different hospitals, and to recommend solution for the problems found during the interpretation of ALK IHC in real world, with the aim of the precise selection of patients who can benefit from ALK targeted therapy. Methods: This was a multicenter and retrospective study. A total of 109 lung adenocarcinoma cases with ALK Ventana-D5F3 IHC staining were collected from 31 lung cancer centers in RATICAL research group from January to June in 2018. All cases were scanned into digital imaging with Ventana iSCANcoreo Digital Slide Scanning System and scored by 31 histopathologists from different centers according to ALK binary (positive or negative) interpretation based on its manufacturer's protocol. The cases with high inconsistency rate were further analyzed using FISH/RT-PCR/NGS. Results: There were 49 ALK positive cases and 60 ALK negative cases, confirmed by re-evaluation by the specialist panel. Two cases (No. 2302 and No.2701) scored as positive by local hospitals were rescored as negative, and were confirmed to be negative by RT-PCR/FISH/NGS. The false interpretation rate of these two cases was 58.1% (18/31) and 48.4% (15/31), respectively. Six out of 31 (19.4%) pathologists got 100% accuracy. The minimum consistency between every two pathologists was 75.8%.At least one pathologist gave negative judgement (false negative) or positive judgement (false positive) in the 49 positive or 60 negative cases, accounted for 26.5% (13/49), 41.7% (25/60), respectively, with at least one uncertainty interpretation accounted for 31.2% (34/109). Conclusion: There are certain heterogeneities and misclassifications in the real world interpretation of ALK-D5F3 IHC test, which need to be guided by the oncoming expert consensus based on the real world data.
|
|---|---|
| Authors | L Li, L P Zhang, Y C Han, W Y Wang, Y Jin, Q X Xia, Y P Liu, J Xiang, C Liu, S S Lu, W Wu, Z Chen, J Pang, Y F Xi, Y S Zheng, D M Gu, J Fan, X N Chang, W W Wang, L Wang, Z H Zhang, X C Yan, Y Sun, J Li, F Hou, J Y Zhang, R F Huang, J P Lu, Z Wang, Y B Hu, H T Yuan, Y J Dong, L Wang, Z Y Ke, J S Geng, L Guo, J Zhang, J M Ying, RATICAL (ALK testing in Chinese advanced non-small cell lung cancer patients: a national-wide multicenter prospective real world study) Research Group |
| Journal | Zhonghua bing li xue za zhi = Chinese journal of pathology (Zhonghua Bing Li Xue Za Zhi) Vol. 48 Issue 12 Pg. 921-927 (Dec 08 2019) ISSN: 0529-5807 [Print] China |
| PMID | 31818064 (Publication Type: Journal Article, Multicenter Study) |
| Chemical References |
|
| Topics |
|
Join CureHunter, for free Research Interface BASIC access!
Realize the full power of the drug-disease research graph!